Cyclodx 7.4 Gbq (Fludeoxyglucose 18f SOLUTION) 7.4 GBQ

CYCLODX 7.4 GBQ is a solution containing Fludeoxyglucose 18F, used for diagnostic imaging. This intravenous solution is manufactured by CIUSS de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke in Canada.

Strength

7.4 GBQ

Pack Size

20ML

Manufacturer / TM Owner

CIUSS DE L'ESTRIE - CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CYCLODX 7.4 GBQ is primarily used in positron emission tomography (PET) scans to help diagnose and monitor various conditions. Fludeoxyglucose 18F, the active ingredient, aids in visualizing metabolic processes in the body. This solution is administered intravenously and is designed for diagnostic purposes in medical imaging.

Side Effects

The effects of CYCLODX 7.4 GBQ are typically observed during PET scans, where it helps in highlighting areas of high metabolic activity. This can assist healthcare professionals in identifying abnormalities. Common effects may include temporary discomfort at the injection site, but these are generally mild and short-lived.

Precautions & Warnings

CYCLODX 7.4 GBQ should be handled with care, following proper safety protocols for radioactive materials. It is important to use this solution under the supervision of a qualified healthcare professional. Patients should inform their healthcare provider about any allergies or medical conditions before administration.

Avoid Interactions

CYCLODX 7.4 GBQ may interact with other medications or substances, so it is crucial to disclose all current treatments to your healthcare provider. Specific interactions with alcohol or other common substances are not well-documented, but general precautions should be taken to avoid any potential complications.

Frequently Asked Questions

CYCLODX 7.4 GBQ is used in PET scans to help diagnose and monitor various conditions by visualizing metabolic activity.

CYCLODX 7.4 GBQ is administered intravenously by a healthcare professional.

Common effects may include temporary discomfort at the injection site, but these are generally mild and short-lived.

CYCLODX 7.4 GBQ should be handled with care, following proper safety protocols for radioactive materials, and used under the supervision of a qualified healthcare professional.

It is important to disclose all current treatments to your healthcare provider to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.